Nyxoah SA (EBR:NYXH)
2.420
-0.065 (-2.62%)
May 21, 2026, 4:00 PM EDT
Nyxoah Revenue
Nyxoah had revenue of 6.37M EUR in the quarter ending March 31, 2026, with 498.87% growth. This brings the company's revenue in the last twelve months to 15.33M, up 251.24% year-over-year. In the year 2025, Nyxoah had annual revenue of 10.02M with 121.63% growth.
Revenue (ttm)
15.33M
Revenue Growth
+251.24%
P/S Ratio
6.89
Revenue / Employee
99.53K
Employees
154
Market Cap
105.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.02M | 5.50M | 121.63% |
| Dec 31, 2024 | 4.52M | 173.00K | 3.98% |
| Dec 31, 2023 | 4.35M | 1.26M | 40.99% |
| Dec 31, 2022 | 3.08M | 2.23M | 261.97% |
| Dec 31, 2021 | 852.00K | 783.00K | 1,134.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 4.11B |
| Fagron NV | 952.17M |
| Ion Beam Applications | 620.18M |
| European Medical Solutions | 52.80M |
| Hyloris Pharmaceuticals | 8.83M |
| Onward Medical | 5.41M |
| Sequana Medical NV | 105.50K |
Nyxoah News
- 1 day ago - Information on the total number of voting rights and shares - GlobeNewsWire
- 1 day ago - Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum - GlobeNewsWire
- 8 days ago - Nyxoah Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 8 days ago - Nyxoah Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 9 days ago - Nyxoah price target lowered to $7 from $9 at Piper Sandler - TheFly
- 9 days ago - Nyxoah Q1 Earnings Call Highlights - MarketBeat
- 9 days ago - Nyxoah reports Q1 EPS (EUR 0.37) vs. (EUR 0.60) last year - TheFly
- 9 days ago - Nyxoah Earnings Call Transcript: Q1 2026 - Transcripts